Melissa Menier

440 total citations
8 papers, 330 citations indexed

About

Melissa Menier is a scholar working on Surgery, Genetics and Molecular Biology. According to data from OpenAlex, Melissa Menier has authored 8 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Melissa Menier's work include Neurogenetic and Muscular Disorders Research (6 papers), Congenital Anomalies and Fetal Surgery (4 papers) and RNA modifications and cancer (2 papers). Melissa Menier is often cited by papers focused on Neurogenetic and Muscular Disorders Research (6 papers), Congenital Anomalies and Fetal Surgery (4 papers) and RNA modifications and cancer (2 papers). Melissa Menier collaborates with scholars based in United States, United Kingdom and Spain. Melissa Menier's co-authors include Jerry R. Mendell, Douglas M. Sproule, Richard Shell, W. David Arnold, Samiah Al-Zaidy, Sukumar Nagendran, Courtney Wells, Linda Lowes, Lindsay N. Alfano and Douglas E. Feltner and has published in prestigious journals such as Neurology, Pediatric Neurology and Molecular Therapy — Methods & Clinical Development.

In The Last Decade

Melissa Menier

8 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melissa Menier United States	5	235	207	151	90	28	8	330
Markus McColly United States	5	250 1.1×	269 1.3×	165 1.1×	87 1.0×	29 1.0×	12	408
Natalie F. Reash United States	7	153 0.7×	214 1.0×	97 0.6×	83 0.9×	46 1.6×	20	314
A. de Kleyn United States	3	248 1.1×	284 1.4×	150 1.0×	179 2.0×	39 1.4×	8	455
Louise Deschênes Canada	5	117 0.5×	298 1.4×	170 1.1×	40 0.4×	16 0.6×	10	356
David Schorling Germany	10	408 1.7×	325 1.6×	241 1.6×	76 0.8×	29 1.0×	18	526
Tamara Dangouloff Belgium	9	399 1.7×	276 1.3×	257 1.7×	50 0.6×	22 0.8×	21	468
Jena M. Krueger United States	6	153 0.7×	127 0.6×	99 0.7×	46 0.5×	17 0.6×	13	228
Maite Calucho Spain	6	358 1.5×	287 1.4×	229 1.5×	19 0.2×	8 0.3×	7	411
André Macedo Serafim da Silva Brazil	10	88 0.4×	121 0.6×	61 0.4×	22 0.2×	28 1.0×	33	323
Rodrigo de Holanda Mendonça Brazil	8	137 0.6×	89 0.4×	87 0.6×	21 0.2×	10 0.4×	29	254

Countries citing papers authored by Melissa Menier

Since Specialization

Citations

This map shows the geographic impact of Melissa Menier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Menier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Menier more than expected).

Fields of papers citing papers by Melissa Menier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Menier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Menier. The network helps show where Melissa Menier may publish in the future.

Co-authorship network of co-authors of Melissa Menier

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Menier. A scholar is included among the top collaborators of Melissa Menier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Menier. Melissa Menier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Servais, Laurent, Darryl C. De Vivo, Janbernd Kirschner, et al.. (2022). Effectiveness and Safety of Onasemnogene Abeparvovec in Older Patients with Spinal Muscular Atrophy (SMA): Real-World Outcomes from the RESTORE Registry (S39.002). Neurology. 98(18_supplement). 2 indexed citations

Day, John, Richard S. Finkel, Eugenio Mercuri, et al.. (2021). Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovec. Molecular Therapy — Methods & Clinical Development. 21. 76–82. 38 indexed citations

Al-Zaidy, Samiah, Stephen J. Kolb, Linda Lowes, et al.. (2019). AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History Cohort. Journal of Neuromuscular Diseases. 6(3). 307–317. 128 indexed citations

Dabbous, Omar, Douglas M. Sproule, Douglas E. Feltner, et al.. (2019). Event-Free Survival and Motor Milestone Achievement Following AVXS-101 and Nusinersen Interventions Contrasted to Natural History for Type I Spinal Muscular Atrophy Patients (S25.005). Neurology. 92(15_supplement). 4 indexed citations

Lowes, Linda, Lindsay N. Alfano, W. David Arnold, et al.. (2019). Impact of Age and Motor Function in a Phase 1/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement Therapy. Pediatric Neurology. 98. 39–45. 133 indexed citations

Cardenas, Jessica, Melissa Menier, Marjet D. Heitzer, & Douglas M. Sproule. (2018). High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids’ Inpatient Database (KID). PharmacoEconomics - Open. 3(2). 205–213. 17 indexed citations

Nichols, Thom R., et al.. (2014). A convex urostomy pouch with adhesive border: a patient survey. British Journal of Nursing. 23(22). 1182–1186. 7 indexed citations

Nichols, Thom R., et al.. (2011). Evaluating the process of skin barrier selection through use of a specific tool. Gastrointestinal Nursing. 9(Sup3). 10–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact